Cardiac Wellness Supplements
Home | Contact | Help
McAfee Secure sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams
Cart (0 items)
Research
banners/wellcor_plan

What makes a healthy heart?

Clinical studies have examined the impact of nutrients on blood pressure. A healthy diet can help reduce the likelihood of developing hypertension as well as to maintain better control of blood pressure in hypertension patients. Exercise is also an important aspect of a healthy lifestyle. For many, proper diet and exercise may not be enough. Supplementing your diet is important.
banners/research

Who is Lee A. Surkin, MD, FACC, FCCP?

Dr. Surkin is a practicing Yale-trained cardiologist, who also has a Master of Science in Human Nutrition from Columbia University. Click here to read Dr. Surkin's biography, mission and vision, philosophy and the latest news about Dr. Surkin and his specially-formulated heart health supplements, WELLCOR.
banners/cor_pak
Alpha Lipoic Acid
CoEnzyme Q10
Green Tea
Hawthorn
L-Carnitine
Omega 3
Quercetin
Resveratrol

Alpha Lipoic Acid



Reverse Oxidative Stress in the Heart with Alpha Lipoic Acid



Jung H. Suh, Eric T. Shigeno, Jason D. Morrow, Brian Cox, Alma E. Rocha, Balz Frei, and Tory M. Hagen



Linus Pauling Institute and Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon 97331, USA; and Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA



Abstract: Oxidative stress has been implicated as a causal factor in the aging process of the heart and other tissues. To determine the extent of age-related myocardial oxidative stress, oxidant production, antioxidant status, and oxidative DNA damage were measured in hearts of young (2 months) and old (28 months) male Fischer 344 rats. Cardiac myocytes isolated from old rats showed a nearly threefold increase in the rate of oxidant production compared to young rats, as measured by the rates of 2,7-dichlorofluorescin diacetate oxidation. Determination of myocardial antioxidant status revealed a significant twofold decline in the levels of ascorbic acid (P 5 0.03), but not a-tocopherol. A significant age-related increase (P 5 0.05) in steadystate levels of oxidative DNA damage was observed, as monitored by 8-oxo-2*-deoxyguanosine levels. To investigate whether dietary supplementation with (R)-a-lipoic acid (LA) was effective at reducing oxidative stress, young and old rats were fed an AIN-93M diet with or without 0.2% (w/w) LA for 2 wk before death. Cardiac myocytes from old, LA-supplemented rats exhibited a markedly lower rate of oxidant production that was no longer significantly different from that in cells from unsupplemented, young rats. Lipoic acid supplementation also restored myocardial ascorbic acid levels and reduced oxidative DNA damage. Our data indicate that the aging rat heart is under increased mitochondrial-induced oxidative stress, which is significantly attenuated by lipoic acid supplementation. Suh, J. H., Shigeno, E. T., Morrow, J. D., Cox, B., Rocha, A. E., Frei, B., Hagen, T. M. Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-a-lipoic acid. FASEB J. 15, 700-706 (2001)



Key Words: aging z cardiac myocytes z oxidative stress z lipoic acid



Aging is associated with an increased incidence of cardiac arrhythmias and diastolic and systolic dysfunction, which may ultimately lead to heart failure. Heart failure alone is the leading cause of hospitalization, permanent disability, and death in persons over the age of 65 [1] in the U.S. Because of the enormous suffering and health care burden that cardiac dysfunction causes, much effort has gone into understanding the mechanisms leading to age-related myocardial decline. It has been difficult, however, to separate the effects of aging per se from those of age-associated diseases (atherosclerosis, diabetes, hypertension) on cardiac performance. Thus, the relative contribution of to myocardial dysfunction is not well defined.



Even though the mechanisms leading to alterations in cardiac performance are not well understood, there is reason to suspect increased oxidative stress to significantly contribute to myocardial dysfunction with age. It is generally agreed that isolated mitochondrial preparations from old compared to young hearts produce more reactive oxygen species (ROS), reflecting an age-related decline in coupling of electron transport to ATP production. These changes in mitochondria may lead to the reported increase in superoxide and hydrogen peroxide production in mitochondria prepared from old vs. young rats [2,4]. Thus, it is conceivable that dietary interventions with antioxidants, which could augment endogenous antioxidant compounds to either prevent the formation or quench the higher levels of oxidants, could provide an effective means to improve or maintain myocardial function with age.



(R)-a-lipoic acid (LA) is a thiol compound found naturally in plants and animals [4]. Lipoamide dehydrogenases, found only in mitochondria, reduce free LA to dihydrolipoic acid, which is a potent antioxidant. Thus, LA supplementation may increase cellular and mitochondrial antioxidant status, thereby effectively attenuating any putative increase in oxidative stress with age [5].



Aside from acting as a potent antioxidant in its own right, LA increases or maintains levels of other low molecular weight antioxidants such as ubiquinone, glutathione (GSH), and ascorbic acid. LA may exert these effects by sparing or reducing, ubiquinone [6], GSH, and vitamin C [7] or, in the case of GSH, by increasing the cellular uptake of cysteine [8], which is the rate-limiting substrate for GSH biosynthesis.



The purpose of the present study was to 1) examine the age-related changes to myocardial oxidant production, low molecular weight antioxidant status, and indices of oxidative damage, and 2) determine whether dietary supplementation of lipoic acid could improve those indices of oxidative stress. Overall, our results show that the aging rat myocardium exhibits increased oxidant production, significantly lower ascorbic acid levels, and a marked increase in steady-state levels of oxidative DNA damage. LA supplementation significantly reverses the age-related decline in myocardial ascorbic acid content, and lowers the rate of oxidant production and the steady-state levels of oxidative DNA damage. Our results thus indicate that dietary supplementation with lipoic acid may be an effective means tolower increased myocardial oxidative stress with age.



Results: To determine the effects of aging on the general metabolic rate, O2 consumption in freshly isolated cardiac myocytes from young and old rats was determined. O2 consumption in cells from young rats was 3.18 6 0.53 mmol O2/min per 106 cells. In contrast, O2 consumption in cardiac myocytes from old rats was 1.74 6 0.13 mmol O2/min per 106 cells, a 45% decline compared to young rats. These results suggest an age-associated decrease in the basal metabolic rate of the cardiac myocytes.



To examine how the decline in mitochondrial function affected cellular oxidant production, the rates of DCFH oxidation in freshly isolated cardiac myocytes from old and young rats were determined. In cardiac myocytes isolated from old rats, total cellular oxidant production was 125% higher than in myocytes from young rats. This increase in oxidant production was even more pronounced when normalized to the rates of oxygen consumption. Thus, the rate of DCFH fluorescence per mmol O2 consumed was threefold higher in cardiac myocytes from old rats compared to young rats. These results strongly suggest that, with age, cardiac myocytes are under increased oxidative stress, possibly due to a decline in mitochondrial function. To investigate the effects of this age-associated increase in oxidative stress on cellular antioxidant capacities, ascorbate and a-tocopherol levels in the freshly isolated hearts from old and young rats were measured. Consistent with the data on oxidant production, we observed a 57% decrease in the tissue ascorbate concentration of old rats (1.4060.87 nmol/mg protein) compared to young rats (3.0861.10 pmol/mg tissue (P50.02). In contrast, no age-related decrease in vitamin E levels was observed (0.9760.29 and 1.1660.62 nmol/mg protein in hearts from young and old). This result suggests that there is a differential consumption of water-soluble vs. lipid-soluble antioxidants in vivo due to aging.



To further explore this notion of different levels of oxidative stress with aging in the aqueous and lipid compartments, we examined oxidative damage to DNA, as assessed by the levels of 8-oxo-dG, and lipids, as assessed by levels of F2-isoprostanes. Consistent with the pattern of antioxidant depletion with age, we found a twofold increase in oxidative DNA damage in the heart of old rats (4.0064.80-oxo-dG/105 dG bases) compared to young rats (2.0160.25 8-oxo-dG/105 dG bases (P50.002). In contrast, the levels of F2-isoprostanes in hearts from old rats (3.7460.41 ng/g wet tissue) were not significantly different from those in young rats (3.4760.02 ng/g wet tissue). These results suggest that in the heart, macromolecules in an aqueous environment may be more susceptible to damage due to age-associated increase in oxidative stress than membrane lipids.



In light of the above evidence of increased oxidative stress in the aging heart, we examined whether supplementation with (R)-a-lipoic acid can reverse the decline in mitochondrial function and reduce oxidative stress. To this end, Fischer 344 rats of varying ages (young: 2 months; old: 24-28 months) were fed an AIN-93M diet with or without 0.2% (w/w) (R)-a-lipoic acid for 2wk. Results show a significant decrease in the cellular oxidant production in the old LA-supplemented vs. old unsupplemented animals. In agreement withthese data, we also found a significant twofold improvement in ascorbate levels in the hearts from old LA treated vs. untreated animals (2.9060.36 vs 1.462.9nmol/mg protein, respectively; P50.03). In fact, cardiac ascorbate levels in LA-fed old rats were not different from those in young rats (2.9060.72 nmol/mg protein). However, a similar increase in tissue ascorbate levels was not achieved by LA feeding to young rats. Furthermore, there was no effect of LA treatment on the levels of a-tocopherol.


To investigate whether the decreased ROS production and increased ascorbate levels in LA-treated old rats translated into a decrease in oxidative damage to DNA and lipids, 8-oxo-dG and F2-isoprostane levels were measured. Indeed, we found a 30% decrease in cardiac 8-oxo-dG levels in the supplemented old rats (2.8460.39 8-oxo-dG/105 dG bases) compared to their age-matched controls (4.0060.40 8-oxo-dG/105 dG bases (P50.05). In the young animals, LA supplementation did not alter the steady-state levels of 8-oxo-dG in the heart. As expected, treatment with LA had no effect on the steady-state levels of F2-isoprostanes in young or old rats. Thus, by decreasing the rate of oxidant production and increasing the level of antioxidant protection in the aqueous phase, LA treatment caused a marked reversal in steady-state levels of 8-oxo-dG in old rats to levels found in the young rats.



1. Cohn, J. N., Bristow, M. R., Chien, K. R., Colucci, W. S., Frazier, O. H., Leinwand, L. A., Lorell, B. H., Moss, A. J., Sonnenblick, E. H., Walsh, R. A., et al. (1997) Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation 95, 766-770
2. Sawada, M., and Carlson, J. C. (1987) Changes in superoxide radical and lipid peroxide formation in the brain, heart and liver during the lifetime of the rat. Mech. Ageing Dev. 41, 125-137
3. Nohl, H., and Hegner, D. (1978) Do mitochondria produce oxygen radicals in vivo? Eur. J. Biochem. 82, 563-567
4. Sohal, R. S., Ku, H. H., Agarwal, S., Forster, M. J., and Lal, H. (1994) Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech. Ageing Dev. 74, 121-133
5. Haramaki, N., Han, D., Handelman, G. J., Tritschler, H. J., and Packer, L. (1997) Cytosolic and mitochondrial systems for NADH-and NADPH-dependent reduction of alpha-lipoic acid. Free Radic. Res. Med. 22, 535-542
6. Kozlov, A. V., Gille, L., Staniek, K., and Nohl, H. (1999) Dihydrolipoic acid maintains ubiquinone in the antioxidant active form by two-electron reduction of ubiquinone and oneelectron reduction of ubisemiquinone. Arch. Biochem. Biophys. 363, 148-154 7. Roy, S., and Packer, L. (1998) Redox regulation of cell functions by alpha-lipoate: biochemical and molecular aspects. Biofactors 7, 263-267
8. Han, D., Handelman, G., Marcocci, L., Sen, C. K., Roy, S., Kobuchi, H., Tritschler, H. J., Flohe, L., and Packer, L. (1997) Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. Biofactors 6, 321-338
9. Tytgat, J. (1994) How to isolate cardiac myocytes. Cardiovasc. Res. 28, 280-283
10. Farmer, B. B., Mancina, M., Williams, E. S., and Watanabe, A. M. (1983) Isolation of calcium tolerant myocytes from adult rat hearts: review of the literature and description of a method. Life Sci 33, 18
11. Frei, B., England, L., and Ames, B. N. (1989) Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. USA 86, 6377-6381
12. Chou, P. P., Jaynes, P. K., and Bailey, J. L. (1985) Determination of vitamin E in microsamples of serum by liquid chromatography with electrochemical detection. Clin. Chem. 31, 880-882
13. Helbock, H. J., Beckman, K. B., Shigenaga, M. K., Walter, P. B., Woodall, A. A., Yeo, H. C., and Ames, B. N. (1998) DNA oxidation matters: the HPLC-electrochemical detection assay of 8-oxo deoxyguanosine and 8-oxo-guanine. Proc. Natl. Acad. Sci. USA 95, 288-293
14. Morrow, J. D., Awad, J. A., Kato, T., Takahashi, K., Badr, K. F., Roberts, L. J. D., and Burk, R. F. (1992) Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J. Clin. Invest. 90, 2502-2507
15. Hansford, R. G., Hogue, B. A., and Mildaziene, V. (1997) Dependence of H2O2 formation by rat heart mitochondria on substrate availability and donor age. J. Bioenerg. Biomembr. 29, 89-95
16. Hagen, T. M., Yowe, D. L., Bartholomew, J. C., Wehr, C. M., Do, K. L., Park, J. Y., and Ames, B. N. (1997) Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase. Proc. Natl. Acad. Sci. USA 94, 3064-3069
17. Awad, J. A., Morrow, J. D., Hill, K. E., Roberts, L. J., Burk R.F.,. (1994) Detection and localization of lipid peroxidation in selenium and vitamin E deficient rats using F2-isoprostanes. J. Nutr. 124, 810-816
18. Morrow, J. D., Roberts, L. J., Daniel, V. C., Awad, J. A., Mirochnitchenko, O., Swift, L. L., and Burk, R. F. (1998). Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo effects of oxygen tension and glutathione. Arch. Biochem. Biophys. 353, 160-171
19. Lodge, J. K., Traber, M. G., and Packer, L. (1998) Thiol chelation of Cu21 by dihydrolipoic acid prevents human low density lipoprotein peroxidation. Free Radic. Biol. Med. 25, 287-297
20. Buettner, G. R. (1993) The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch. Biochem. Biophys. 300, 535-543
21. Nakagawa, Y., Cotgreave, I. A., and Moldeus, P. (1991) Relationships between ascorbic acid and alpha-tocopherol during diquat-induced redox cycling in isolated rat hepatocytes. Biochem. Pharmacol. 42, 883-888
22. Wang, Z., Ciabattoni, G., Creminon, C., Lawson, J., Fitzgerald, G. A., Patrono, C., and Maclouf, J. (1995) Immunological characterization of urinary 8-epi-prostaglandin F2 excretion in man. J. Pharmacol. Exp. Ther. 363, 148-154
23. Lykkesfeldt, J., Hagen, T. M., Vinarsky, V., and Ames, B. N. (1998) Age-associated decline in ascorbic acid concentration, recycling, and biosynthesis in rat hepatocytes reversal with (R)-alpha-lipoic acid supplementation. FASEB J. 12, 1183-1189
24. Souza-Pinto, N. C., Croteau, D. L., Hudson, E. K., Hansford, R. G., and Bohr, V. A. (1999) Age-associated increase in 8-oxo-deoxyguanosine glycosylase/AP lyase activity in rat mitochondria. Nucleic Acids Res. 27, 1935-1942
25. Nakai, N., Sato, Y., Oshida, Y., Yoshimura, A., Fujitsuka, N., Sugiyama, S., and Shimomura, Y. (1997) Effects of aging on the activities of pyruvate dehydrogenase complex and its kinase in rat heart. Life Sci. 60, 2309-2314
26. Humphries, K. M., and Szweda, L. I. (1998) Selective inactivation of alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal. Biochemistry 37, 15835-15841
27. Hagen, T. M., Ingersoll, R. T., Wehr, C. M., Lykkesfeldt, J., Vinarsky, V., Bartholomew, J. C., Song, M. H., and Ames, B. N. (1998) Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity. Proc. Natl. Acad. Sci. USA 95, 9562-9566
28. Hoch, F. L. (1992) Cardiolipins and biomembrane function. Biochim. Biophys. Acta 1113, 71-133
29. Katz, A. M. (1991) Energetics and the failing heart. Hosp. Pract. 26, 78-90
30. Morgan, J. P., Erny, R. E., Allen, P. D., Grossman, W., and Gwathmey, J. K. (1990) Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation 81, III21-III32
31. Negretti, N., O'Neill, S. C., and Eisner, D. A. (1993) The relative contributions of different intracellular and sarcolemmal systems to relaxation in rat ventricular myocytes. Cardiovasc. Res. 27, 1826-1830
32. Frolkis, V. V., Frolkis, R. A., Mkhitarian, L. S., Shevchuk, V. G., Fraifeld, V. E., Vakulenko, L. G., and Syrovy, I. (1988) Contractile function and Ca21 transport system of myocardium in ageing. Gerontology 34, 64-74
33. Siri, F. M., Krueger, J., Nordin, C., Ming, Z., and Aronson, R. S. (1991) Depressed intracellular calcium transients and contraction in myocytes from hypertrophied and failing guinea pig hearts. Am. J. Physiol. 261. H 514-H530
WELLCOR Slim Premium Weight Loss
COR-PAK: The Essentials
STRENGTH:  Coenzyme Q10 & Hawthorn
GUARD:  Resveratrol & Quercetin
ENERGIZE:  Supreme Green Tea
DEFENSE:  Premium Omega 3
CONTROL:  Alpha Lipoic Acid/L-Carnitine
*This statement has not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent disease.
Copyright © 2009. Please read our Privacy Returns Policies.
We accept all major forms of payment